Skip to main content
. 2022 May 12;12:764621. doi: 10.3389/fonc.2022.764621

Figure 1.

Figure 1

The screening of the CRC prognosis-relative dysregulated lncRNAs. (A) The colorectal cancer-related dysregulation lncRNAs based on the bioinformatic screening. (B) 18 colorectal cancer prognosis-associated lncRNAs, including 11 downregulation and 7 upregulation. (C) The Kaplan-Meier curves of FAM222A-AS1 based on the TCGA database. (D) The expression of FAM222A-AS1 in the colorectal normal tissues, para-carcinoma tissues and tumor tissues from the TCGA database. (E) The expression of FAM222A-AS1 in the 50 pairs clinical colorectal para-carcinoma and cancer tissues. (F) Kaplan-Meier analysis showed the association between FAM222A-AS1 expression and overall survival of CRC patients (n = 50).FC, Fold change. ***P < 0.001.